.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent research introduces a psychological breakthrough in occupational health through the Health Impairment Grief Scale (HIGS). This tool specifically measures health loss-related grief among employees on long-term sick leave. Often, clinicians might mistake these reactions for clinical depression or anxiety. However, this study proves that grief over lost physical or mental health is a distinct psychological phenomenon. Consequently, understanding this distinction is crucial for Indian medical professionals managing rising workplace stress levels and chronic illness cases.
Furthermore, the HIGS helps rehabilitation professionals differentiate between distinct emotional responses. The 10-item scale provides a structured way to assess how sickness absence impacts an employee's sense of self. During the psychometric evaluation of 226 sick-listed employees, researchers found the scale to be remarkably robust. Specifically, the items showed clear differentiation from symptoms of clinical depression. Therefore, doctors can use this tool to identify patients who require support for mourning their previous state of health rather than standard mood disorders.
Moreover, the HIGS highlights the link between current health loss and anticipated work-related losses. Employees often worry about their future career path while recovering from chronic conditions. By addressing these interconnected emotional challenges, specialists can create more effective rehabilitation plans. This comprehensive approach addresses both the physical recovery and the psychological mourning process. Ultimately, recognizing health loss-related grief enables a more empathetic and successful return to the workforce, reducing the risk of long-term disability.
It refers to the emotional reaction and mourning process an individual experiences due to the loss of their health, physical abilities, or professional identity following a sickness or injury.
The scale allows clinicians to identify specific grief reactions that general depression screenings might miss, ensuring that patients receive tailored psychological support during their recovery and return-to-work journey.
Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.
References
van Eersel JHW et al. Health loss-related grief among sick-listed employees: development and validation of the health impairment grief scale. Disabil Rehabil. 2026 Feb 06. doi: 10.1080/09638288.2026.2624530. PMID: 41646007.
ADP Research Institute. People at Work 2023: A Global Workforce View. 2023.
World Health Organization. Mental Health in the Workplace. 2022.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New Health Impairment Grief Scale (HIGS) validates health loss-related grief as a distinct psychological phenomenon in sick-listed employees. Learn more....
7 months ago
Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
